ABSTRACT
Objective To investigate and analyze the clinical analysis and nursing intervention of intravenous thrombolysis with urokinase in the treatment of acute myocardial infarction. Methods 40 patients with acute myocardial infarction treated in Hangzhou Hospital of Zhejiang Medical and Health Group from February 2015 to August 2016 were selected and randomly divided into the control group and the experimental group, with 20 patients in each group. The control group received routine treatment, intravenous drip of nitroglycerin and subcutaneous injection of low molecular weight heparin. On this basis, the experimental group was given urokinase intravenous thrombolysis treatment. Two groups of patients were given reasonable nursing intervention measures to improve the quality of care. The therapeutic effects of the experimental group and the control group were compared and analyzed. Results After the corresponding treatment, the effective number of patients in the experimental group was 19 cases (95.0%). In the control group, the effective number of treatment was 13 cases (65.0%). The effective rate of treatment in the experimental group was significantly higher than that in the control group, with statistical difference (P<0.05). The remission time of the chest pain in the control group was (15.32±7.21) h, and the remission time of the chest pain in the experimental group was (2.72±0.67) h. The improvement time of chest pain in the experimental group was significantly shorter than that in the control group, with statistical difference (P<0.05). In addition, the probability of complications in the experimental group was 10%, which was significantly lower than that in the control group (40.0%), and there was a statistical difference (P<0.05). Conclusion Intravenous thrombolysis with urokinase in treatment of acute myocardial infarction treatment effect is ideal, can improve clinical symptoms in a large extent, improve the efficiency of treatment, the treatment of high safety, with the further promotion of the clinical significance.
ABSTRACT
Objective To investigate and analyze the clinical analysis and nursing intervention of intravenous thrombolysis with urokinase in the treatment of acute myocardial infarction. Methods 40 patients with acute myocardial infarction treated in Hangzhou Hospital of Zhejiang Medical and Health Group from February 2015 to August 2016 were selected and randomly divided into the control group and the experimental group, with 20 patients in each group. The control group received routine treatment, intravenous drip of nitroglycerin and subcutaneous injection of low molecular weight heparin. On this basis, the experimental group was given urokinase intravenous thrombolysis treatment. Two groups of patients were given reasonable nursing intervention measures to improve the quality of care. The therapeutic effects of the experimental group and the control group were compared and analyzed. Results After the corresponding treatment, the effective number of patients in the experimental group was 19 cases (95.0%). In the control group, the effective number of treatment was 13 cases (65.0%). The effective rate of treatment in the experimental group was significantly higher than that in the control group, with statistical difference (P<0.05). The remission time of the chest pain in the control group was (15.32±7.21) h, and the remission time of the chest pain in the experimental group was (2.72±0.67) h. The improvement time of chest pain in the experimental group was significantly shorter than that in the control group, with statistical difference (P<0.05). In addition, the probability of complications in the experimental group was 10%, which was significantly lower than that in the control group (40.0%), and there was a statistical difference (P<0.05). Conclusion Intravenous thrombolysis with urokinase in treatment of acute myocardial infarction treatment effect is ideal, can improve clinical symptoms in a large extent, improve the efficiency of treatment, the treatment of high safety, with the further promotion of the clinical significance.
ABSTRACT
The socioeconomic status of the patients is the important factor for post-exposure prophylaxis (PEP). However, few investigations were designed to study the correlation between the socioeconomic status and PEP. This study set out to determine the importance of socioeconomic status for PEP. All of the 11,670 at-risk populations of rabies in the public health centre of San Sheng County in Chengdu from January 2002 to December 2009 were reviewed retrospectively. We identified 11,350 patients on vaccination and 550 patients with rabies immunoglobulin. RIG was administered to 4.85% bite victims attending the rabies prevention clinics, while 61.36% had a category III exposure. The incidence of receiving RIG in the population of the high level of income (49.38%) was much higher than the groups of the medium level (8.08%) and the low level of income (1.46%) (P<0.05). The incidence of receiving RIG with above high school (23.08%) was much higher than the groups of the primary school (3.01%), the junior school (12.56%) and the illiteracy (2.08%) (P<0.05). In the logistic regression analysis by stepwise approach, the socioeconomic status was the most important factor for PEP (95% CI 1.20-2.04). Vaccination and immunoglobulin proved to be the most prominent two factors for PEP but whether receiving Vaccination and immunoglobulin treatment or not is determined by the socioeconomic status. So, the socioeconomic status was the most important factor for PEP.
